Direkt zum Inhalt
Merck
  • Purification of mouse hepatic non-parenchymal cells or nuclei for use in ChIP-seq and other next-generation sequencing approaches.

Purification of mouse hepatic non-parenchymal cells or nuclei for use in ChIP-seq and other next-generation sequencing approaches.

STAR protocols (2021-03-23)
Ty D Troutman, Hunter Bennett, Mashito Sakai, Jason S Seidman, Sven Heinz, Christopher K Glass
ZUSAMMENFASSUNG

Significant advancements in understanding disease mechanisms can occur through combined analysis of next-generation sequencing datasets generated using purified cell populations. Here, we detail our optimized protocol for purification of mouse hepatic macrophages (or other liver non-parenchymal populations) suitable for use in various next-generation sequencing protocols. An alternative framework is described for sorting pre-fixed hepatic nuclei populations. This strategy has the advantage of rapidly preserving the nuclei and can facilitate success with ChIP-seq for more challenging molecules. For complete details on the use and execution of these protocols, please refer to Muse et al. (2018), Sakai et al. (2019), and Seidman et al. (2020).

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
IGEPAL® CA-630, for molecular biology
Sigma-Aldrich
Flavopiridol -hydrochlorid, ≥98% (HPLC), powder
Sigma-Aldrich
Magnesiumchlorid -Lösung, BioUltra, for molecular biology, ~1 M in H2O